I love the difference in styles between SR and DW.
SR is talking to everyone with industry ears attentive, yet commercial at the same time.
DW is an entrepreneur, goes to the root of the issue for teh company and shareholders with a growth / commercial overtone.
For example the announcement is formal and specifically related to Trials related to Diabetic Foot Ulcers, but DW goes further to mention venous leg ulcers. (as the product is designed for both). DW just gets you thinking of the commercial opportunities right out front. Got to love them both, I think this is going to be a beautiful combination.
GLTAH
I love the difference in styles between SR and DW. SR is talking...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.24 |
Change
-0.020(0.88%) |
Mkt cap ! $1.546B | |||
| Open | High | Low | Value | Volume |
| $2.26 | $2.27 | $2.23 | $2.045M | 909.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 39647 | $2.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.24 | 4080 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.25 |
Change
-0.020 ( 0.46 %) |
||||
| Open | High | Low | Volume | ||
| $2.26 | $2.27 | $2.23 | 216364 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PNV (ASX) Chart |